Compare Novartis with HCL Infosys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs HCL INFOSYS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS HCL INFOSYS NOVARTIS/
HCL INFOSYS
 
P/E (TTM) x 49.9 119.7 41.7% View Chart
P/BV x 2.0 - - View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 NOVARTIS   HCL INFOSYS
EQUITY SHARE DATA
    NOVARTIS
Mar-21
HCL INFOSYS
Mar-21
NOVARTIS/
HCL INFOSYS
5-Yr Chart
Click to enlarge
High Rs77012 6,234.8%   
Low Rs5014 13,688.5%   
Sales per share (Unadj.) Rs154.510.7 1,441.5%  
Earnings per share (Unadj.) Rs8.5-6.0 -141.7%  
Cash flow per share (Unadj.) Rs13.4-5.8 -229.0%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.2-7.3 -3,966.4%  
Shares outstanding (eoy) m24.69329.21 7.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.10.7 550.8%   
Avg P/E ratio x75.1-1.3 -5,604.6%  
P/CF ratio (eoy) x47.5-1.4 -3,466.2%  
Price / Book Value ratio x2.2-1.1 -200.2%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,6912,635 595.4%   
No. of employees `000NANA-   
Total wages/salary Rs m1,085805 134.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,8143,528 108.1%  
Other income Rs m3321,133 29.3%   
Total revenues Rs m4,1464,660 89.0%   
Gross profit Rs m267-2,482 -10.7%  
Depreciation Rs m12243 284.8%   
Interest Rs m77556 13.8%   
Profit before tax Rs m400-1,948 -20.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m19120 966.7%   
Profit after tax Rs m209-1,967 -10.6%  
Gross profit margin %7.0-70.4 -9.9%  
Effective tax rate %47.8-1.0 -4,701.8%   
Net profit margin %5.5-55.8 -9.8%  
BALANCE SHEET DATA
Current assets Rs m9,2243,116 296.0%   
Current liabilities Rs m3,5738,279 43.2%   
Net working cap to sales %148.2-146.4 -101.3%  
Current ratio x2.60.4 685.9%  
Inventory Days Days176362 48.6%  
Debtors Days Days379 412.4%  
Net fixed assets Rs m2,4803,859 64.3%   
Share capital Rs m123658 18.7%   
"Free" reserves Rs m7,018-3,059 -229.4%   
Net worth Rs m7,141-2,401 -297.5%   
Long term debt Rs m0590 0.0%   
Total assets Rs m11,7036,976 167.8%  
Interest coverage x6.2-2.5 -248.0%   
Debt to equity ratio x0-0.2 0.0%  
Sales to assets ratio x0.30.5 64.4%   
Return on assets %2.4-20.2 -12.1%  
Return on equity %2.981.9 3.6%  
Return on capital %6.776.9 8.7%  
Exports to sales %9.30-   
Imports to sales %016.9 0.0%   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNA597 0.0%   
Fx inflow Rs m35433 1,084.6%   
Fx outflow Rs m974597 163.3%   
Net fx Rs m-621-564 110.1%   
CASH FLOW
From Operations Rs m-692-148 468.9%  
From Investments Rs m952204 465.6%  
From Financial Activity Rs m-368-222 166.0%  
Net Cashflow Rs m-109-164 66.0%  

Share Holding

Indian Promoters % 0.0 62.9 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.9 0.2 494.4%  
FIIs % 0.1 0.0 600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 37.1 79.0%  
Shareholders   44,370 185,130 24.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   UNIPHOS ENT    REDINGTON    FUTURE CONSUMER    SUNDRAM FASTENERS    MMTC    



Today's Market

Sensex Rallies 632 Points, Nifty Ends Above 16,350; Banking & IT Stocks Witness Buying(Closing)

Indian share markets rose today as easing bets about aggressive interest rate hikes by central banks lifted sentiment.

Related Views on News

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


May 27, 2022 03:30 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS